# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-008460
Filing Date
2025-02-27
Accepted
2025-02-27 08:15:43
Documents
95
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-k.htm iXBRL | 10-K | 1818812
2 |  | ex4-7.htm | EX-4.7 | 67833
3 |  | ex19.htm | EX-19 | 5420
4 |  | ex21-1.htm | EX-21.1 | 4193
5 |  | ex23-1.htm | EX-23.1 | 5175
6 |  | ex31-1.htm | EX-31.1 | 17851
7 |  | ex31-2.htm | EX-31.2 | 17668
8 |  | ex32-1.htm | EX-32.1 | 8238
9 |  | ex32-2.htm | EX-32.2 | 8242
10 |  | ex19_001.jpg | GRAPHIC | 1029348
11 |  | ex19_002.jpg | GRAPHIC | 1164577
12 |  | ex19_003.jpg | GRAPHIC | 879613
13 |  | ex19_004.jpg | GRAPHIC | 1317323
14 |  | ex19_005.jpg | GRAPHIC | 1311250
15 |  | ex19_006.jpg | GRAPHIC | 574340
| Complete submission text file | 0001493152-25-008460.txt |  | 15956084

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
16 | XBRL SCHEMA FILE | imnn-20241231.xsd | EX-101.SCH | 50002
17 | XBRL CALCULATION FILE | imnn-20241231_cal.xml | EX-101.CAL | 70939
18 | XBRL DEFINITION FILE | imnn-20241231_def.xml | EX-101.DEF | 186756
19 | XBRL LABEL FILE | imnn-20241231_lab.xml | EX-101.LAB | 465950
20 | XBRL PRESENTATION FILE | imnn-20241231_pre.xml | EX-101.PRE | 363751
98 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-k_htm.xml | XML | 866347

Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15911 | Film No.: 25673155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)